Article

Private practice safely integrates CK

Author(s):

San Diego-An evaluation of the first group of patients to undergo conductive keratoplasty (CK) performed by Ronald Friedman, MD, indicates that the procedure can be safely used to treat hyperopia and presbyopia and is easily introduced into an average-volume practice with a refractive and cataract base.

Of the 50 eyes, six had undergone a previous LASIK procedure and one had undergone a cataract extraction. All eyes had 20/20 vision preoperatively and were disease free. The average patient age was 54 years (female to male ratio: 3:1).

When he started performing CK, Dr. Friedman mostly did eight-spot treatments, which reflected his initial conservatism with the procedure and the relatively large number of patients who had undergone a previous LASIK procedure.

When evaluating his results, he looked at the change in refraction achieved, the enhancement rate, the complications that developed, and patient satisfaction.

"When we looked at the refractive change resulting from the eight-spot treatment, most patients achieved between 0 and 1.5 D of correction," Dr. Friedman reported. "When the eyes that had undergone LASIK were eliminated from the evaluation, the amount of the refractive change decreased substantially to 0.75 D, although a large number of eyes still achieved more than that.

"When considering the 16-spot treatment, there was an even distribution of correction among all the achieved ranges; this did not change significantly when the eyes that had undergone LASIK were removed," he added. "Slightly less than half of those eyes received the intended correction of 1.25 D. The eyes that underwent the 24-spot treatment all achieved more than 0.75 D of correction, and only one eye in this group achieved more than the intended 1.75 D of correction."

Regarding near vision postoperatively, all eyes could read J7 or smaller, and most eyes had J1 to J3 vision.

The level of induced astigmatism was greater than 1 D in four eyes 1 week after the surgery and in six eyes 1 month after surgery. Most of these eyes required an enhancement procedure because the induced oblique, or with-the-rule, astigmatism was not tolerated well, Dr. Friedman pointed out.

"Enhancements were performed on eight of the 50 eyes because of undercorrection; most of these eyes [originally] had an eight-spot treatment. Four eyes had an enhancement procedure because of induced astigmatism," Dr. Friedman reported. "Overall, 24% of the 50 eyes had an enhancement procedure, which was performed 1 month after the initial procedure. The enhancements done to correct induced astigmatism consisted of the placement of one or two spots guided by the results of topography and wavefront analysis."

Overcorrections occurred in three eyes, keratitis developed in three eyes, and iritis developed in two eyes, the latter two of which required treatment with topical steroids. No patient lost best spectacle-corrected visual acuity.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.